This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Daniel Peeper group

DanielPeeper.jpg

Daniel Peeper

Group Leader, Head of Division

Personal details

Experience

Biographic sketch

Daniel Peeper received his PhD in the laboratory of Alex van der Eb at the University of Leiden (The Netherlands, 1994), for his work on adenoviral oncoproteins and cell cycle-regulatory proteins. He received his first postdoctoral training in the laboratory of Mark Ewen  (Dana-Farber Cancer Institute, Boston, USA), where he discovered the functional connection between Ras and the retinoblastoma protein. During a second postdoctoral period in the laboratory of René Bernards (Netherlands Cancer Institute), he studied cellular protection against oncogenic transformation, by using function-based genome-wide screens. He received a senior research position at the Netherlands Cancer Institute in 2000. In 2002, as a Principal Investigator he began running his own laboratory at this institute, first in the Division of Molecular Genetics.

In 2002, Peeper became Assistant Professor at the Netherlands Cancer Institute. Three years later he received a permanent staff position and Associate Professorship at the same Institute.  Also in that year, Peeper was elected as an EMBO Young Investigator. In 2006, he was awarded an NWO VICI grant on synthetic lethality screens for novel anticancer drug targets. In 2007, he received the first Queen Wilhelmina Award (awarded by her Majesty the Queen and the minister of Education, on behalf of the Netherlands Cancer Society KWF; € 2 million), for his work on melanoma in collaboration with W. Mooi (VUmc). In the same year, he received the Society for Melanoma Research (SMR) Jr. Researcher Award. In 2008, Peeper was appointed Professor (part time) of Functional Oncogenomics at the VUmc. In the same year, he was elected as EMBO member. In 2012, he was elected as Member of the Executive and Educational Committees of the European Association for Cancer Research (EACR). Recently, Peeper, together with Anton Berns, David Adams, Mike Stratton and colleagues received a € 15 million ERC Synergy grant for "COMBATCANCER", the development of combinatorial cancer therapy. Peeper is Head of the Division of Molecular Oncology and Chair of the Scientific Council at the Netherlands Cancer Institute.

Share this page